|
FY2021
12 months to Dec 31, 2022
|
FY2020
12 months to Dec 31, 2021
|
|
|---|---|---|
| Cash Flows From Operating Activities: | ||
| Net income | ||
| Formation and operating costs paid by related parties | ||
| Adjustments to reconcile net income to net cash used in operating activities: | ||
| Investment income earned on investment held in Trust Account | ||
| Change in fair value of derivative warrant liabilities | ||
| Changes in operating assets and liabilities: | ||
| Prepaid expenses | ||
| Other assets | ||
| Accounts payable and accrued expenses | ||
| Net Cash used in Operating Activities | ||
| Cash Flows From Investing Activities: | ||
| Cash deposited into Trust Account | ||
| Net Cash used in Investing Activities | ||
| Cash Flows From Financing Activities: | ||
| Proceeds from sale of Units in Public Offering, net of underwriting fee | ||
| Proceeds from sale of Private Placement Warrants | ||
| Proceeds from Sponsor note | ||
| Repayment of advances from Sponsor | ||
| Net Cash provided by Financing Activities | ||
| Net change in cash | ||
| Cash at beginning of period | ||
| Cash at end of period | ||
| Supplemental disclosure of non-cash financing activities: | ||
| Deferred underwriters' commission charged to temporary equity in connection with the Public Offering | ||
| Operating costs paid by related party which were charged to additional paid-in capital | ||
| Deferred offering costs paid by related party | ||
| Deferred offering costs included in accrued offering costs | ||
| Operating costs paid by related party |
Loading...
